The Nifty opened at 14747.35 with a gap down of 147 points. The index first moved on the upside and recorded its intraday high at 14855.45. The rally quickly fizzled out and prices have started drifting downwards. A sharp decline of more than 250 points brought prices to its intraday low at 14601.70. The index finally closed at 14631.10 near its intraday low with a loss of 263.80 points. All the sectoral indices have seen a decline except Pharma which closed with a gain of more than 1%. The Banks ad Financials have led the bears and closed lower by more than 2.50%. Nifty continued trading volatile and the index ended below 14700 support. An attempt to fill the gap down fizzled out quickly. Bears came at a higher level and pushed prices even lower. Financials have led the decline as HDFC twins have ended lower by more than 4%. As we explained earlier, ‘The index has rallied more than 700 points in the last few trading days so a correction is possible.’ That correction came as Nifty has seen a down move of more than 400 points from its previous swing high in just two days. The index has broken 14700 support and now heading towards 14500 support. A buying opportunity will emerge if Nifty hold its support at 14500. On Monday we should look for a buying opportunity above 14600 with a stop at 14490 and target of 14850.
Bank Nifty opened at 33112.40 with a gap down of 552 points. The index first moved up and recorded its intraday high at 33455.25.Prices then saw a sharp intraday fall to recorded its intraday low at 32663.60. The index finally closed at 32781.80 near its intraday low with a loss of 950 points. Private Banks have underperformed and closed lower by 2.35% while PSU Banks have also closed lower by 1.04%. Within the index, HDFC Bank contributed highest on the downside followed by ICICI Bank.
Bank Nifty continued trading volatile for the second consecutive day.
Trade AnyTime AnyWhere With Elite Empower Mobile App
|SUNPHARMA||654.45||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 645 and for the target 675|
|IOC||90.85||BUY||The stock has given a breakout from a narrow trading range. The stock can be bought at CMP with a stop at 88 and for the target 95|
Get All Your Mutual Fund Portfolio Retuns on Your Mobile by Elite Kuber App
|STOCK OPTION||Strike Price||Buy/Sell||CMP||Initiation||Stop Loss||Target||Remarks|
|PFC||110 CE||BUY||3.95||CMP||2.4||7||OI increase|
|Long Buildup||Short Buildup|
|Stocks||Price||Price%||OI %||OI||Stocks||Price||Price%||OI %||OI|
|COLPAL.21.05 May||1486.4||0.25||2561.94||3549700||ADANIPORTS.21.05 May||735.1||-1.5||4587.34||71716250|
|TATAPOWER.21.05 May||99.3||1.69||2518.77||114898500||PEL.21.05 May||1685.2||-0.12||2566.52||3395150|
|BHEL.21.05 May||48.55||2.97||2489.53||93534000||TATAMOTORS.21.05 May||294.75||-2.47||2143.63||93357450|
|SUNTV.21.05 May||546.85||5.3||2323.83||14797500||HAVELLS.21.05 May||993.8||-1.64||1943.62||4567500|
|APLLTD.21.05 May||992.2||1.18||2281.11||1178650||ULTRACEMCO.21.05 May||6306.7||-1.16||1914.24||2390900|
|Short Covering||Long Unwinding|
|Stocks||Price||Price%||OI%||OI||Stocks||Price||Price %||OI %||OI|
|GAIL.21.05 May||138||2.45||-20.72||31671200||TATACONSUM.21.05 May||670.75||-0.15||-43.42||6813450|
Get Stock Market Recommendation By Our Research Analysts
TOP DELIVERY PERCENTAGE
|Stocks||Price||%Chg||Total Qty||Delivery||Del %||% Change|
|Mphasis Limited||1764.8||-0.29||457673||377404||66.57||Nifty Pharma||13469.25||1.28||59720250|
|Colgate Palmolive (india||1481.9||-0.26||725194||355425||64.21||Nifty Metal||4847.95||-0.15||165263479|
|Hindustan Petroleum Corp||234.65||2.15||15563433||3905242||63.62||Nifty Energy||18031.1||-0.18||2878877|
|Petronet Lng Limited||239.95||2.17||3756006||1406443||63.02||Nifty Media||1547.95||-0.36||517820156|
|Hdfc Life Insurance Comp||665.1||-1.42||2742166||2420410||61.44||Nifty it||25664.45||-0.81||2060214|
|Infosys Limited||1354.35||-0.15||8354677||3130945||57.85||Nifty Realty||309.6||-0.83||2147483500|
|Larsen & Toubro Infotech||3890.25||1.02||303588||144987||56.24||Nifty Fmcg||33623.45||-1.13||760159|
|Tech Mahindra Limited||960.4||-1.69||3129105||1536386||55.92||Nifty Auto||9640.85||-1.36||82931563|
|Torrent Pharma Ltd.||2509.25||0.35||183152||210966||55.05||Nifty 50||14631.1||-1.77||54611487|
|Tata Consultancy Serv Lt||3035.65||-2.56||3072305||837567||51.66||Nifty Bank||32781.8||-2.77||24329636|
UPCOMING ECONOMIC DATA
|INR: Nikkei Markit Manufacturing PMI (Apr) on 3rd May, 2021
INR: Preliminary Trade Data on 3rd May, 2021
|•USD : ISM Manufacturing PMI (Apr) on 3rd May, 2021
•USD: Trade Balance (Mar) on 4th May, 2021
|• India’s goods and services tax collection touched an all-time high as the economy continues to rebound after the disruption caused by the pandemic. GST revenue for March, collected in April, was around Rs 1,41,384 crore, according to a statement from the Ministry of Finance on Saturday. That was 14% higher than the previous month.
•Reliance Industries Ltd (RIL) on Friday reported consolidated net profit of Rs 13,227 crore for the quarter ended March 31, 2021 (Q4FY21), up 108 per cent from Rs 6,348 crore logged in the corresponding quarter last year (Q4FY20). Sequentially, the profit rose 1 per cent. It was Rs 13,101 crore in the December quarter (Q3FY21). The company’s board declared a dividend of Rs 7 per share for the financial year 2020-21. The oil-to-telecom conglomerate’s revenue from operations rose 11 per cent to Rs 1.54 trillion as compared to Rs 1.39 trillion in the year-ago period.
•Maruti Suzuki India Ltd. posted total sales of 159,691 units in April. This is a de-growth of 4.3% over the 167,014 units it sold last month.
•Tata Motors Ltd.’s passenger vehicle division sold 25,095 units in April, the company said in a statement on Saturday. Passenger vehicle sales fell 15% over last month. Year-on-year the domestic sales are not comparable because of covid led lockdown last year. Overall Tata Motors’ domestic sales fell 41% to 39,530 units in April from 66,609 units it sold in March.
•Escorts Ltd.’s agri machinery segment sold 6,979 tractors in March declined 43% over the last month.
Source: Economic Times, Indian Express ,Business Today, Livemint, Business Standard, Bloomberg Quint
|Company Name||Purpose||Ex-Date||Company Name||Purpose||Ex-Date|
|APOLLOTRI||Audited Results||03-May-21||SBILIFE||Audited Results||03-May-21|
|GODREJPROP||Audited Results||03-May-21||SGRL||Audited Results;Final Dividend||03-May-21|
|IDBI||Audited Results||03-May-21||SUPREMEIND||Audited Results;Final Dividend||03-May-21|
|JK AGRI||Audited Results;Dividend||03-May-21||TATACHEM||Audited Results;Final Dividend||03-May-21|
|KOTAKBANK||Audited Results;Dividend||03-May-21||TBZ||Audited Results;Final Dividend;General||03-May-21|
|PILITA||Audited Results||03-May-21||UNIVARTS||A.G.M.;Audited Results;General||03-May-21|
|Company Name||Ex-Date||Purpose||Company Name||Ex-Date||Purpose|
|SANGHVIFOR||03-May-21||Resolution Plan -Suspension||ALLSEC||06-May-21||Interim Dividend – Rs. – 15.00|
|STOVACQ||03-May-21||Dividend – Rs. – 22.00||APTECHT||06-May-21||Interim Dividend – Rs. – 2.2500|
|GDL||04-May-21||Interim Dividend – Rs. – 5.00||EMBASSY||06-May-21||Income Distribution (InvIT)|
|LXMIATO||04-May-21||Consolidation of Shares||PRIMEFRESH||06-May-21||Bonus issue 2:1|
|CRISIL||05-May-21||Interim Dividend – Rs. – 7.00||SRIND||06-May-21||E.G.M.|
|SALORAINTL||05-May-21||E.G.M.||SEZAL||07-May-21||Resolution Plan -Suspension|
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, firstname.lastname@example.org
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing email@example.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail firstname.lastname@example.org.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.